FEASIBILITY OF THE CYTOSPONGE COUPLED WITH TISSUE BIOMARKERS IN EARLY DIAGNOSIS OF OESOPHAGEAL SQUAMOUS CELL CARCINOMA AND SURVEILLANCE OF HIGH-RISK INDIVIDUALS: PRELIMINARY RESULTS FROM THE EDEN STUDY

Aisha Yusuf  ¹     Maryla Turkot  ²     Shalini Malhotra  ³     Nastazja Pilonis  ⁴     Karol Nowicki-Osuch  ⁵     Maria O'Donovan  ⁵     Andrzej Mroz  ⁵     Malgorzata Lenarcik  ⁵     Michal Mikula  ⁶     Monika Wojtowicz-Popiel  ⁶     Massimiliano di Pietro  ⁶     Jaroslaw Regula  ⁷     Michal Filip Kaminski  ⁸     Rebecca Fitzgerald  ⁹     Wladyslaw Januszewicz  ^9    
1 University of Cambridge, Cambridge, United Kingdom
² Centre of Postgraduate Medical Education, Warsaw, Poland
³ Addenbrooke's Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
⁴ Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
⁵ Columbia University, New York, United States
⁶ Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland
⁷ Maria Sklodowska-Curie National Research Institute of Oncology and Centre of Postgraduate Medical Ed, Warsaw, Poland
⁸ Maria Sklodowska-Curie Memorial Center and Institute of Oncology, Warsaw, Poland
⁹ Medical Research Council Hutchison / MRC Research Centre MRC Cancer Unit - MRC Cancer Unit, Medical, Cambridge, United Kingdom

Topic
Digestive Oncology, Endoscopy, Oesophagus

Session
Endoscopic treatment of Barrett's and oesophageal neoplasia

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)